{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T10:08:12Z","timestamp":1774001292706,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515011885"],"award-info":[{"award-number":["2023A1515011885"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22307024"],"award-info":[{"award-number":["22307024"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32394010"],"award-info":[{"award-number":["32394010"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.bmcl.2026.130561","type":"journal-article","created":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T23:29:03Z","timestamp":1769470143000},"page":"130561","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Discovery of furo[2,3-b]isoquinoline derivatives as novel Pks13 inhibitors with reduced hERG inhibition"],"prefix":"10.1016","volume":"134","author":[{"given":"Jiangfeng","family":"Tian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyang","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weijie","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xupeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zihe","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuying","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bmcl.2026.130561_bb0005","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1186\/s12866-025-04206-x","article-title":"Dysbiosis associated with enhanced microbial mobility across the respiratory tract in pulmonary tuberculosis patients","volume":"25","author":"Qin","year":"2025","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.bmcl.2026.130561_bb0010","first-page":"2024","author":"Organization, W. H","year":"2024","journal-title":"Global tuberculosis report"},{"issue":"5","key":"10.1016\/j.bmcl.2026.130561_bb0015","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41573-024-00897-5","article-title":"Therapeutic developments for tuberculosis and nontuberculous mycobacterial lung disease","volume":"23","author":"Dartois","year":"2024","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"10.1016\/j.bmcl.2026.130561_bb0020","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12929-020-00667-6","article-title":"Of tuberculosis and non-tuberculous mycobacterial infections \u2013 a comparative analysis of epidemiology, diagnosis and treatment","volume":"27","author":"Gopalaswamy","year":"2020","journal-title":"J Biomed Sci"},{"issue":"1","key":"10.1016\/j.bmcl.2026.130561_bb0025","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/1060028013504087","article-title":"Bedaquiline","volume":"48","author":"Chahine","year":"2013","journal-title":"Ann Pharmacother"},{"issue":"7","key":"10.1016\/j.bmcl.2026.130561_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0102135","article-title":"Acquired resistance of mycobacterium tuberculosis to bedaquiline","volume":"9","author":"Andries","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bmcl.2026.130561_bb0035","doi-asserted-by":"crossref","first-page":"1056608","DOI":"10.3389\/fmicb.2022.1056608","article-title":"Anti-tuberculosis drug development via targeting the cell envelope of mycobacterium tuberculosis","volume":"13","author":"Xu","year":"2022","journal-title":"Front Microbiol"},{"key":"10.1016\/j.bmcl.2026.130561_bb0040","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.meegid.2016.09.004","article-title":"Overview on mechanisms of isoniazid action and resistance in mycobacterium tuberculosis","volume":"45","author":"Unissa","year":"2016","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.bmcl.2026.130561_bb0045","doi-asserted-by":"crossref","first-page":"710","DOI":"10.3389\/fmicb.2017.00710","article-title":"EthA\/R-independent killing of mycobacterium tuberculosis by ethionamide","volume":"8","author":"Ang","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1016\/j.bmcl.2026.130561_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.717045","article-title":"Mechanism of action, resistance, synergism, and clinical implications of delamanid against multidrug-resistant mycobacterium tuberculosis","volume":"12","author":"Khoshnood","year":"2021","journal-title":"Front Microbiol"},{"issue":"3","key":"10.1016\/j.bmcl.2026.130561_bb0055","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41594-022-00918-0","article-title":"Structure and dynamics of the essential endogenous mycobacterial polyketide synthase Pks13","volume":"30","author":"Kim","year":"2023","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.bmcl.2026.130561_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115702","article-title":"Targeting polyketide synthase 13 for the treatment of tuberculosis","volume":"259","author":"Xia","year":"2023","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2026.130561_bb0065","doi-asserted-by":"crossref","unstructured":"Aggarwal, A.; Parai, M. K.; Shetty, N.; Wallis, D.; Woolhiser, L.; Hastings, C.; Dutta, N. K.; Galaviz, S.; Dhakal, R. C.; Shrestha, R.; Wakabayashi, S.; Walpole, C.; Matthews, D.; Floyd, D.; Scullion, P.; Riley, J.; Epemolu, O.; Norval, S.; Snavely, T.; Robertson, G. T.; Rubin, E. J.; Ioerger, T. R.; Sirgel, F. A.; van der Merwe, R.; van Helden, P. D.; Keller, P.; B\u00f6ttger, E. C.; Karakousis, P. C.; Lenaerts, A. J.; Sacchettini, J. C., Development of a novel lead that targets M. tuberculosis polyketide synthase 13. Cell 2017, 170 (2), 249.","DOI":"10.1016\/j.cell.2017.06.025"},{"issue":"19","key":"10.1016\/j.bmcl.2026.130561_bb0070","doi-asserted-by":"crossref","first-page":"13240","DOI":"10.1021\/acs.jmedchem.2c01064","article-title":"Structure-based optimization of coumestan derivatives as polyketide synthase 13-thioesterase (Pks13-TE) inhibitors with improved hERG profiles for mycobacterium tuberculosis treatment","volume":"65","author":"Zhang","year":"2022","journal-title":"J Med Chem"},{"issue":"22","key":"10.1016\/j.bmcl.2026.130561_bb0075","doi-asserted-by":"crossref","first-page":"15380","DOI":"10.1021\/acs.jmedchem.3c01514","article-title":"Identification and optimization of novel inhibitors of the polyketide synthase 13 thioesterase domain with antitubercular activity","volume":"66","author":"Green","year":"2023","journal-title":"J Med Chem"},{"issue":"9","key":"10.1016\/j.bmcl.2026.130561_bb0080","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.3390\/molecules27092844","article-title":"Design, synthesis and biological evaluation of N-phenylindole derivatives as Pks13 inhibitors against mycobacterium tuberculosis","volume":"27","author":"Cai","year":"2022","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.bmcl.2026.130561_bb0085","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1146\/annurev-pharmtox-010617-053110","article-title":"Human induced pluripotent stem cell (hiPSC)-derived cells to assess drug cardiotoxicity: opportunities and problems","volume":"58","author":"Magdy","year":"2018","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"2","key":"10.1016\/j.bmcl.2026.130561_bb0090","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3390\/biology11020209","article-title":"High-throughput chemical screening and structure-based models to predict hERG inhibition","volume":"11","author":"Krishna","year":"2022","journal-title":"Biology"},{"issue":"6","key":"10.1016\/j.bmcl.2026.130561_bb0095","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ceca.2004.01.008","article-title":"Drugs, hERG and sudden death","volume":"35","author":"Brown","year":"2004","journal-title":"Cell Calcium"},{"issue":"2","key":"10.1016\/j.bmcl.2026.130561_bb0100","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/med.21445","article-title":"Development of safe drugs: the hERG challenge","volume":"38","author":"Kalyaanamoorthy","year":"2017","journal-title":"Med Res Rev"},{"key":"10.1016\/j.bmcl.2026.130561_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112290","article-title":"hERG toxicity assessment: useful guidelines for drug design","volume":"195","author":"Garrido","year":"2020","journal-title":"Eur J Med Chem"},{"issue":"22","key":"10.1016\/j.bmcl.2026.130561_bb0110","doi-asserted-by":"crossref","first-page":"12329","DOI":"10.1073\/pnas.210244497","article-title":"A structural basis for drug-induced long QT syndrome","volume":"97","author":"Mitcheson","year":"2000","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.bmcl.2026.130561_bb0115","unstructured":"Zhou Sheng-bin.; Wang Jiang.; Liu Hong., Lead compound optimization strategy (5) \u2013 reducing the hERG cardiac toxicity in drug development. Acta Pharmaceutica Sinica 2016, 51 (10), 1530."},{"issue":"5","key":"10.1016\/j.bmcl.2026.130561_bb0120","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1021\/acs.macromol.8b00218","article-title":"Phenolic naphthoxazines as curing promoters for benzoxazines","volume":"51","author":"Kaya","year":"2018","journal-title":"Macromolecules"},{"issue":"44","key":"10.1016\/j.bmcl.2026.130561_bb0125","doi-asserted-by":"crossref","first-page":"12946","DOI":"10.1021\/ja027965y","article-title":"Phase-vanishing reactions that use fluorous media as a phase screen. Facile, controlled bromination of alkenes by dibromine and dealkylation of aromatic ethers by boron tribromide","volume":"124","author":"Ryu","year":"2002","journal-title":"J Am Chem Soc"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X26000284?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X26000284?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T07:18:55Z","timestamp":1773991135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X26000284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":25,"alternative-id":["S0960894X26000284"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2026.130561","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of furo[2,3-b]isoquinoline derivatives as novel Pks13 inhibitors with reduced hERG inhibition","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2026.130561","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"130561"}}